PURPOSE: Image reconstruction including the modelling of the point spread function (PSF) is an approach improving the resolution of the PET images. This study assessed the quantitative improvements provided by the implementation of the PSF modelling in the reconstruction of the PET data using the High Resolution Research Tomograph (HRRT). METHODS: Measurements were performed on the NEMA-IEC/2001 (Image Quality) phantom for image quality and on an anthropomorphic brain phantom (STEPBRAIN). PSF reconstruction was also applied to PET measurements in two cynomolgus monkeys examined with [(18)F]FE-PE2I (dopamine transporter) and with [11C]MNPA (D2 receptor), and in one human subject examined with [11C]raclopride (D2 receptor). RESULTS: PSF reconstruction increased the recovery coefficient (RC) in the NEMA phantom by 11-40% and the grey to white matter ratio in the STEPBRAIN phantom by 17%. PSF reconstruction increased binding potential (BP (ND)) in the striatum and midbrain by 14 and 18% in the [18F]FE-PE2I study, and striatal BP (ND) by 6 and 10% in the [11C]MNPA and [11C]raclopride studies. CONCLUSION: PSF reconstruction improved quantification by increasing the RC and thus reducing the partial volume effect. This method provides improved conditions for PET quantification in clinical studies with the HRRT system, particularly when targeting receptor populations in small brain structures.
PURPOSE: Image reconstruction including the modelling of the point spread function (PSF) is an approach improving the resolution of the PET images. This study assessed the quantitative improvements provided by the implementation of the PSF modelling in the reconstruction of the PET data using the High Resolution Research Tomograph (HRRT). METHODS: Measurements were performed on the NEMA-IEC/2001 (Image Quality) phantom for image quality and on an anthropomorphic brain phantom (STEPBRAIN). PSF reconstruction was also applied to PET measurements in two cynomolgus monkeys examined with [(18)F]FE-PE2I (dopamine transporter) and with [11C]MNPA (D2 receptor), and in one human subject examined with [11C]raclopride (D2 receptor). RESULTS: PSF reconstruction increased the recovery coefficient (RC) in the NEMA phantom by 11-40% and the grey to white matter ratio in the STEPBRAIN phantom by 17%. PSF reconstruction increased binding potential (BP (ND)) in the striatum and midbrain by 14 and 18% in the [18F]FE-PE2I study, and striatal BP (ND) by 6 and 10% in the [11C]MNPA and [11C]raclopride studies. CONCLUSION: PSF reconstruction improved quantification by increasing the RC and thus reducing the partial volume effect. This method provides improved conditions for PET quantification in clinical studies with the HRRT system, particularly when targeting receptor populations in small brain structures.
Authors: Margaret E Daube-Witherspoon; Joel S Karp; Michael E Casey; Frank P DiFilippo; Horace Hines; Gerd Muehllehner; Vilim Simcic; Charles W Stearns; Lars-Eric Adam; Steve Kohlmyer; Vesna Sossi Journal: J Nucl Med Date: 2002-10 Impact factor: 10.057
Authors: Andrew G Horti; Hong Fan; Hiroto Kuwabara; John Hilton; Hayden T Ravert; Daniel P Holt; Mohab Alexander; Anil Kumar; Arman Rahmim; Ursula Scheffel; Dean F Wong; Robert F Dannals Journal: J Nucl Med Date: 2006-10 Impact factor: 10.057
Authors: P Karlsson; L Farde; C Halldin; C G Swahn; G Sedvall; C Foged; K T Hansen; B Skrumsager Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530
Authors: Sjoerd J Finnema; Nicholas Seneca; Lars Farde; Evgeny Shchukin; Judit Sóvágó; Balázs Gulyás; Håkan V Wikström; Robert B Innis; John L Neumeyer; Christer Halldin Journal: Nucl Med Biol Date: 2005-05 Impact factor: 2.408
Authors: Ikuo Odano; Christer Halldin; Per Karlsson; Andrea Varrone; Anu J Airaksinen; Raisa N Krasikova; Lars Farde Journal: Neuroimage Date: 2008-12-24 Impact factor: 6.556
Authors: S G Hasselbalch; K Madsen; C Svarer; L H Pinborg; S Holm; O B Paulson; G Waldemar; G M Knudsen Journal: Neurobiol Aging Date: 2007-06-04 Impact factor: 4.673
Authors: David Matuskey; Patrick Worhunksy; Elizabeth Correa; Brian Pittman; Jean-Dominique Gallezot; Nabeel Nabulsi; Jim Ropchan; Venkatesh Sreeram; Rohit Gudepu; Edward Gaiser; Kelly Cosgrove; Yu-Shin Ding; Marc N Potenza; Yiyun Huang; Robert T Malison; Richard E Carson Journal: Neuroimage Date: 2016-02-11 Impact factor: 6.556
Authors: K Collste; P Plavén-Sigray; H Fatouros-Bergman; P Victorsson; M Schain; A Forsberg; N Amini; S Aeinehband; S Erhardt; C Halldin; L Flyckt; L Farde; S Cervenka Journal: Mol Psychiatry Date: 2017-02-14 Impact factor: 15.992
Authors: Kati Alakurtti; Sargo Aalto; Jarkko J Johansson; Kjell Någren; Terhi Tuokkola; Vesa Oikonen; Matti Laine; Juha O Rinne Journal: J Cereb Blood Flow Metab Date: 2010-05-05 Impact factor: 6.200
Authors: Aurelija Jucaite; Per Stenkrona; Zsolt Cselényi; Serena De Vita; Nuria Buil-Bruna; Katarina Varnäs; Alicia Savage; Andrea Varrone; Peter Johnström; Magnus Schou; Chris Davison; Andy Sykes; Venkatesh Pilla Reddy; Matthias Hoch; Ana Vazquez-Romero; Mohammad Mahdi Moein; Christer Halldin; Melinda S Merchant; Martin Pass; Lars Farde Journal: Neuro Oncol Date: 2021-04-12 Impact factor: 12.300